发明名称 |
Treatment of Cognitive Impairment With PDE4 Inhibitor |
摘要 |
This invention relates to the treatment of varying degrees of cognitive impairment associated with, for example, aging, Alzheimer's disease, schizophrenia with low dose administration of a PDE4 inhibitor, specifically roflumilast. |
申请公布号 |
US2015051254(A1) |
申请公布日期 |
2015.02.19 |
申请号 |
US201414460905 |
申请日期 |
2014.08.15 |
申请人 |
Takeda GmbH |
发明人 |
Prickaerts Jos;van Duinen Marlies;Sambeth Anke;Blokland Arjan |
分类号 |
A61K31/44 |
主分类号 |
A61K31/44 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating cognitive impairment associated with Alzheimer's disease, schizophrenia or aging in a mammal in need of such treatment, comprising administering to a mammal suffering from cognitive impairment associated with Alzheimer's disease, schizophrenia or aging a phosphodiesterase 4 inhibitor selected from the group consisting of roflumilast, a pharmaceutically acceptable salt of roflumilast, roflumilast-N-oxide and a pharmaceutically acceptable salt of roflumilast-N-oxide, wherein the phosphodiesterase 4 inhibitor is administered at a daily dose of between 50 and 300 mcg. |
地址 |
Konstanz DE |